Showing 2381-2390 of 5105 results for "".
Permanent Life Insurance, Part 2
https://practicaldermatology.com/topics/practice-management/permanent-life-insurance-part-2/23462/Who should use it and how, and who should not utilize this type of insurance.Six Dos and Don’ts of Communicating with Patients During COVID-19
https://practicaldermatology.com/topics/practice-management/six-dos-and-donts-of-communicating-with-patients-during-covid-19/23446/From patients with eczema to those considering aesthetic interventions, your audience seeks simple, predictable communication.Currents: Patient-Focused Approaches to Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/currents-patient-focused-approaches-to-eczema/23444/Permanent Life Insurance: What It Is and Why a New Law Has Made It Better
https://practicaldermatology.com/topics/practice-management/permanent-life-insurance-what-it-is-and-why-a-new-law-has-made-it-better/23443/A review of what this insurance offers.Physician Spotlight: Peter van de Kerkhof, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-peter-van-de-kerkhof-md-phd/23431/Joining a New Practice
https://practicaldermatology.com/topics/practice-management/joining-a-new-practice-1/23425/Financial modeling can help you evaluate the merits of a potential position.DermWireTV: 2020 in Review
https://practicaldermatology.com/topics/psoriasis/dermwiretv-2020-in-review/19882/Crisaborole ointment became the first and only steroid-free, topical prescription medication for mild to moderate AD in patients as young as three months of age. Ustekinumab is approved for pediatric patients with moderate to severe plaque psoriasis. FDA approved ixekizumab injection, 80mg/mL for tCaring for the Transgender Patient
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/caring-for-the-transgender-patient/23410/Dr. Doris Day offers pearls on dermatologic care for transgender patients.Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.Snapshot: The Percentage of Dermatology Offices Open During the COVID-19 Pandemic
https://practicaldermatology.com/topics/practice-management/snapshot-the-percentage-of-dermatology-offices-open-during-the-covid-19-pandemic/23404/A survey of practices in two states sheds light on the impact of the novel coronavirus.